Intermittent Versus Continuous Venetoclax With Acalabrutinib for CLL/SLL (NCT07014917)

🔬

Loading study...

Intermittent Versus Continuous Venetoclax With Acalabrutinib for CLL/SLL (NCT07014917) | TrialReferrals